JP Morgan Upgrades Cooper Companies: Here's What You Need To Know
JP Morgan Upgrades Cooper Companies: Here's What You Need To Know
JP Morgan upgraded its rating of Cooper Companies (NASDAQ:COO) to Overweight with a price target of $120.00, changing its price target from $100.00 to $120.00.
摩根大通将其对库珀公司（纳斯达克股票代码：COO）的评级上调至增持，目标股价为120.00美元，将其目标股价从100.00美元上调至120.00美元。
Shares of Cooper Companies are trading up 1.88% over the last 24 hours, at $103.45 per share.
库珀公司的股价在过去24小时内上涨了1.88％，至每股103.45美元。
A move to $120.00 would account for a 16.0% increase from the current share price.
升至120.00美元将导致当前股价上涨16.0％。
About Cooper Companies
关于库珀公司
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
库珀公司是美国最大的眼部护理公司之一，分为两个部门：CooperVision和CooperSurgical。CooperVision是一家纯粹的隐形眼镜企业，由一系列球面、多焦点和复曲面隐形眼镜组成。该公司还拥有世界上最全面的特种镜头产品组合之一。库珀拥有包括Proclear、Biofinity、MyDay和clariti在内的品牌，控制着大约四分之一的美国隐形眼镜市场。CooperSurgical成立于1990年，由与生殖保健、生育和女性护理相关的设备组成。在整个试管婴儿周期中，库珀拥有最广泛的医疗器械覆盖范围。它还拥有Paragard，这是美国唯一的无激素宫内节育器，控制着美国宫内节育器市场的17％。
About Analyst Ratings
关于分析师评级
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
分析师在银行和金融系统工作，通常专门研究股票或特定行业的报告。分析师可以参加公司电话会议和会议，研究公司财务报表，并与内部人士沟通，公布股票的 “分析师评级”。分析师通常每季度对每只股票进行一次评级。
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
一些分析师还将提供增长预期、收益和收入等指标的预测，以为股票提供进一步指导。使用分析师评级的投资者应注意，这种专业建议来自人类，可能会出错。
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.
如果您想跟踪哪些分析师的表现优于其他分析师，可以在Benzinga Pro中查看最新的分析师评级以及分析师成功得分。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。